ORPHA:280062
Calciphylaxis
Publications
3,716
Trials
13
Interventional, condition-specific
Researchers
1,068
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare vascular calcification disorder typically characterized by occlusion of microvessels in the cutaneous tissue resulting in painful cutaneous lesions. The disorder is often life-limiting.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0017215
- MeSH:D002115
- UMLS:C0006666
- NCIT:C84607
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,716 matched papers (1,997 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
13 matched on ClinicalTrials.gov (6 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
3,716
3,716 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
3,716 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
1,997 in the last 10 years · low confidence
Phrase hits: 3,716 · MeSH hits: 95
Who's working on it?
1,068
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Nigwekar SU12 papers · 2026
Department of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Papers in Europe PMC - 02Wang N7 papers · 2026
Wound and Ostomy Care Center, Outpatient Department, Gansu Provincial Hospital, Lanzhou, Gansu, People's Republic of China.
Papers in Europe PMC - 03Lu S6 papers · 2026
Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Papers in Europe PMC - 04Hu J5 papers · 2026
Department of Geriatrics, Division of Nephrology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Papers in Europe PMC - 05Li C5 papers · 2026
Department of Geriatrics, Division of Nephrology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Papers in Europe PMC - 06Liu J5 papers · 2026
State Key Laboratory of Reproductive Medicine and Offspring Health, Center of Clinical Reproductive Medicine, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Women and Children Health Hospital, Nanjing, China.
Papers in Europe PMC - 07Qin L5 papers · 2026
State Key Laboratory of Reproductive Medicine and Offspring Health, Center of Clinical Reproductive Medicine, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Women and Children Health Hospital, Nanjing, China.
Papers in Europe PMC - 08Ye X5 papers · 2026
Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China.
Papers in Europe PMC - 09Zeng M5 papers · 2026
Department of Nephrology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Papers in Europe PMC - 10Zhang L5 papers · 2026
Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
13
interventional trials for this specific condition
13 interventional trials matched this specific condition name; 6 currently recruiting in our sample.
Data as of 27 July 2026
13 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 92.8th percentile).
low confidence · 92.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
13 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04592640·RECRUITING·Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Conditions: Chronic Kidney Diseases · Calciphylaxis · Calcific Uremic Arteriolopathy · Treatment·Matched via name + MeSH
- NCT04654000·RECRUITING·Rheopheresis as Adjuvant Treatment of Calciphylaxis
Conditions: Metabolic Disorder · End Stage Renal Disease · Rare Diseases·Matched via name + MeSH
- NCT07240649·NOT YET RECRUITING·Emerging Indications for Hyperbaric Oxygen Treatment
Conditions: Post-COVID-19 Condition · Ulcerative Colitis · Crohn Disease · Calciphylaxis·Matched via name + MeSH
- NCT07583745·NOT YET RECRUITING·Study of EPN-701 for the Treatment of Calciphylaxis
Conditions: Calciphylaxis·Matched via name + MeSH
- NCT07708038·NOT YET RECRUITING·Anti-Interleukin-6 (IL6) in Calciphylaxis
Conditions: Calciphylaxis·Matched via name + MeSH
- NCT05018221·RECRUITING·Better Evidence and Translation for Calciphylaxis
Conditions: Calciphylaxis·Matched via name + MeSH
Observational and natural-history studies
10 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06065852·RECRUITING·National Registry of Rare Kidney Diseases
Conditions: Adenine Phosphoribosyltransferase Deficiency · AH Amyloidosis · AHL Amyloidosis · AL Amyloidosis·Matched via name + MeSH
- NCT03032835·RECRUITING·Partners Calciphylaxis Biobank
Conditions: Calciphylaxis · Calcific Uremic Arteriolopathy · End Stage Renal Disease · Chronic Kidney Diseases·Matched via name + MeSH
- NCT02280733·RECRUITING·A Real-World Registry of Chronic Wounds and Ulcers
Conditions: Diabetic Foot · Pressure Ulcer · Surgical Wound Dehiscence · Vasculitis·Matched via name + MeSH
- NCT07511283·RECRUITING·Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)
Conditions: Calciphylaxis · Calcific Uremic Arteriolopathy · End Stage Renal Disease (ESRD) · Chronic Kidney Diseases·Matched via name + MeSH
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Calciphylaxis"
MeSH descriptor terms unioned into the query: Calciphylaxis
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Calciphylaxis"
Interventional trials matched via: both (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 13 interventional · 10 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (3716) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T11:49:07.608Z
